Barr Gets License For Generic Actiq As FTC Clears Cephalon-Cima Merger
By Marius Meland ( August 11, 2004, 12:00 AM EDT) -- Cephalon Inc. has granted Barr Laboratories Inc. a license to create a generic version of the pain killer Actiq as part of a deal with antitrust authorities to clear the drug maker's acquisition of Cima Labs Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.